Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Gray Announces Closing of Term Loan and Revolving Credit Facility Refinancing
-
The Catholic University of America Champions Sustainable Future with a Community Solar Project by Standard Solar
-
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Cerence Names Tony Rodriquez as Interim Chief Financial Officer
-
HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer
-
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
HeartSciences Regains Compliance with Nasdaq Listing Requirements
-
Graphjet Technology Receives Notification of Delinquency from Nasdaq
-
CEA Industries Inc. Announces Reverse Stock Split to be Effective June 7, 2024; Publicly Traded Warrant Adjustment
-
3D Systems Provides Important Update on Dental Growth Strategy
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Toyota Motor Corporation Investors to Inquire About Securities Class Action Investigation – TM
-
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
-
PennantPark Floating Rate Capital Ltd. Upsizes Credit Facility to $611 Million
-
Nasdaq May 2024 Volumes
-
Stitch Fix Announces Third Quarter of Fiscal Year 2024 Financial Results
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market initiatives
-
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
-
EZCORP to Participate in June Conferences
-
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
-
Root, Inc. to Participate in the TD Financial Services & Fintech Summit
-
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja California Desalination Project
-
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
-
Root, Inc. to Participate in the TD Financial Services & Fintech Summit
-
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
-
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
-
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
-
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
-
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
-
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
-
World Financial Split Corp. Declares Quarterly Preferred Share Distribution
-
Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Top 10 Split Trust Declares Quarterly Fund Distributions
-
S Split Corp. Declares Monthly Distribution
-
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Celldex Therapeutics to Present at Jefferies Healthcare Conference
-
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
PrairieSky Royalty Declares Quarterly Dividend
-
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies
-
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Novo Resources Corp. Announces Resignation of Ross Hamilton as Director
